Global Oxcarbazepine API Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market can be attributed to the increasing prevalence of epilepsy and other neurological disorders, which are major drivers for the global oxcarbazepine API market.
The global oxcarbazepine API market is segmented on the basis of type, application and region. On the basis of type, it is segmented into medical grade and non-medical grade; on the basis of application it is segmented into tablets and oral suspension; on the basis of region it is segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa regions.
Some Of The Growth Factors Of This Market:
- Oxcarbazepine is a drug used to treat epilepsy and bipolar disorder.
- It is also used to prevent seizures in people with epilepsy who are taking other medications that can cause seizures, or who have had seizures during the past year.
- The drug has been approved for use in more than 100 countries worldwide, including the United States, Canada, Australia and Europe.
- Oxcarbazepine is marketed under the trade name Trileptal by Novartis Pharmaceuticals Corporation.
- The API market growth factors of oxcarbazepine are its efficacy as an anticonvulsant and mood stabilizer.
Industry Growth Insights published a new data on “Oxcarbazepine API Market”. The research report is titled “Oxcarbazepine API Market research by Types (Medical Grade, Other), By Applications (Tablets, Oral Suspension, Other), By Players/Companies Novartis, Sun Pharm, Apotex, Jubilant Pharma, Mylan, Hetero, Teva, BASF, Glenmark, Dr. Reddy’s, F.I.S.(Fabbrica Italiana Sintetici), Euticals, Taro Pharmaceuticals, Humanwell, Zhejiang Jiuzhou Pharmaceutical, CTX Life Sciences, VPL Chemicals, Amoli Organics, Bajaj Healthcare, MSN Laboratories, Shizuoka caffeine, Anuja Healthcare, Taj Pharmaceuticals, Yamamoto Chemical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxcarbazepine API Market Research Report
By Type
Medical Grade, Other
By Application
Tablets, Oral Suspension, Other
By Companies
Novartis, Sun Pharm, Apotex, Jubilant Pharma, Mylan, Hetero, Teva, BASF, Glenmark, Dr. Reddy’s, F.I.S.(Fabbrica Italiana Sintetici), Euticals, Taro Pharmaceuticals, Humanwell, Zhejiang Jiuzhou Pharmaceutical, CTX Life Sciences, VPL Chemicals, Amoli Organics, Bajaj Healthcare, MSN Laboratories, Shizuoka caffeine, Anuja Healthcare, Taj Pharmaceuticals, Yamamoto Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Oxcarbazepine API Market Report Segments:
The global Oxcarbazepine API market is segmented on the basis of:
Types
Medical Grade, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablets, Oral Suspension, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Sun Pharm
- Apotex
- Jubilant Pharma
- Mylan
- Hetero
- Teva
- BASF
- Glenmark
- Dr. Reddy’s
- F.I.S.(Fabbrica Italiana Sintetici)
- Euticals
- Taro Pharmaceuticals
- Humanwell
- Zhejiang Jiuzhou Pharmaceutical
- CTX Life Sciences
- VPL Chemicals
- Amoli Organics
- Bajaj Healthcare
- MSN Laboratories
- Shizuoka caffeine
- Anuja Healthcare
- Taj Pharmaceuticals
- Yamamoto Chemical
Highlights of The Oxcarbazepine API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medical Grade
- Other
- By Application:
- Tablets
- Oral Suspension
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxcarbazepine API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxcarbazepine API is an oral medication used to treat seizures. It is also used to reduce the frequency of seizures in people with epilepsy. Oxcarbazepine API may also be used for other purposes not listed here.
Some of the major players in the oxcarbazepine api market are Novartis, Sun Pharm, Apotex, Jubilant Pharma, Mylan, Hetero, Teva, BASF, Glenmark, Dr. Reddy¢â‚¬â„¢s, F.I.S.(Fabbrica Italiana Sintetici), Euticals, Taro Pharmaceuticals, Humanwell, Zhejiang Jiuzhou Pharmaceutical, CTX Life Sciences, VPL Chemicals, Amoli Organics, Bajaj Healthcare, MSN Laboratories, Shizuoka caffeine, Anuja Healthcare, Taj Pharmaceuticals, Yamamoto Chemical.
The oxcarbazepine api market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxcarbazepine API Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oxcarbazepine API Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oxcarbazepine API Market - Supply Chain
4.5. Global Oxcarbazepine API Market Forecast
4.5.1. Oxcarbazepine API Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oxcarbazepine API Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oxcarbazepine API Market Absolute $ Opportunity
5. Global Oxcarbazepine API Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oxcarbazepine API Market Size and Volume Forecast by Type
5.3.1. Medical Grade
5.3.2. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oxcarbazepine API Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oxcarbazepine API Market Size and Volume Forecast by Application
6.3.1. Tablets
6.3.2. Oral Suspension
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oxcarbazepine API Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oxcarbazepine API Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oxcarbazepine API Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oxcarbazepine API Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oxcarbazepine API Demand Share Forecast, 2019-2026
9. North America Oxcarbazepine API Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oxcarbazepine API Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oxcarbazepine API Market Size and Volume Forecast by Application
9.4.1. Tablets
9.4.2. Oral Suspension
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oxcarbazepine API Market Size and Volume Forecast by Type
9.7.1. Medical Grade
9.7.2. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oxcarbazepine API Demand Share Forecast, 2019-2026
10. Latin America Oxcarbazepine API Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oxcarbazepine API Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oxcarbazepine API Market Size and Volume Forecast by Application
10.4.1. Tablets
10.4.2. Oral Suspension
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oxcarbazepine API Market Size and Volume Forecast by Type
10.7.1. Medical Grade
10.7.2. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oxcarbazepine API Demand Share Forecast, 2019-2026
11. Europe Oxcarbazepine API Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oxcarbazepine API Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oxcarbazepine API Market Size and Volume Forecast by Application
11.4.1. Tablets
11.4.2. Oral Suspension
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oxcarbazepine API Market Size and Volume Forecast by Type
11.7.1. Medical Grade
11.7.2. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oxcarbazepine API Demand Share, 2019-2026
12. Asia Pacific Oxcarbazepine API Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oxcarbazepine API Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oxcarbazepine API Market Size and Volume Forecast by Application
12.4.1. Tablets
12.4.2. Oral Suspension
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oxcarbazepine API Market Size and Volume Forecast by Type
12.7.1. Medical Grade
12.7.2. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oxcarbazepine API Demand Share, 2019-2026
13. Middle East & Africa Oxcarbazepine API Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oxcarbazepine API Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oxcarbazepine API Market Size and Volume Forecast by Application
13.4.1. Tablets
13.4.2. Oral Suspension
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oxcarbazepine API Market Size and Volume Forecast by Type
13.7.1. Medical Grade
13.7.2. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oxcarbazepine API Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oxcarbazepine API Market: Market Share Analysis
14.2. Oxcarbazepine API Distributors and Customers
14.3. Oxcarbazepine API Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novartis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sun Pharm
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Apotex
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Jubilant Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Mylan
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hetero
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BASF
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Glenmark
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Dr. Reddys
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. F.I.S.(Fabbrica Italiana Sintetici)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Euticals
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Taro Pharmaceuticals
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Humanwell
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Zhejiang Jiuzhou Pharmaceutical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. CTX Life Sciences
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. VPL Chemicals
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Amoli Organics
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Bajaj Healthcare
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. MSN Laboratories
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
